Id |
Subject |
Object |
Predicate |
Lexical cue |
T14 |
0-144 |
Sentence |
denotes |
In total, 181 residual serum samples originally collected during the routine examination of 181 patients with severe COVID-19 were investigated. |
T15 |
145-432 |
Sentence |
denotes |
Severe COVID-19 was defining according to guideline of diagnosis and treat for Coronavirus Disease 2019 (7th edition) awarded by National Health Commission of the People's Republic of China, the relevant characteristic symptoms including RR≥30 times/min, Oxygen saturation≤93% and so on. |
T16 |
433-615 |
Sentence |
denotes |
The serum samples were divided based on the different stages of disease during which they were collected: early-stage (1–7 days), middle-stage (8–14 days), and late-stage (≥15 days). |
T17 |
616-772 |
Sentence |
denotes |
The diagnostic criteria used for confirming COVID-19 was based on the guidelines issued by the National Health Commission of the People's Republic of China. |
T18 |
773-948 |
Sentence |
denotes |
All test kits for detection of G, GM, and Mn were provided by the manufacturer (Dynamiker Biotechnology (Tianjin) Co., Ltd, China) using an Automatic ELISA Workstation (A200). |
T19 |
949-1028 |
Sentence |
denotes |
Rank and sum tests were performed, and count data were analyzed with a χ² test. |
T20 |
1029-1095 |
Sentence |
denotes |
Differences were considered statistically significant at p < 0.05. |
T21 |
1096-1277 |
Sentence |
denotes |
There was no significant difference in the mean values and positive rates of G, GM, and Mn between the early-, middle-, and late-stage COVID-19 patient samples (P > 0.05) (Table 1 ). |
T22 |
1278-1499 |
Sentence |
denotes |
However, the positive GM test rate tended to increase with age, i.e., the positive rate of the groups of patients 50–64 years old and aged ≥50 years old were higher than that of the group of patients aged 20–49 years old. |
T23 |
1500-1672 |
Sentence |
denotes |
Table 1 Positive rates of (1,3)-β-D-glucan (G), galactomannan (GM), and Candida mannan (Mn) tests in different stages of disease and age groups in severe COVID-19 patients. |
T24 |
1673-1776 |
Sentence |
denotes |
Stage of disease No. of patients tested No (%) of patients with positive results in each indicated test |
T25 |
1777-1826 |
Sentence |
denotes |
G GM Mn Total (Positive in any of G, GM, MN test) |
T26 |
1827-1879 |
Sentence |
denotes |
Early (1–7 days) 15 3 (20.0) 1 (6.7) 0.00 (0) 20.003 |
T27 |
1880-1936 |
Sentence |
denotes |
Middle (8–14 days) 28 14.28 (4) 7.14 (2) 3.57 (1) 14.284 |
T28 |
1937-1996 |
Sentence |
denotes |
Late (≥15 days) 138 18.11 (25) 7.97 (11) 1.45 (2) 25.3 (35) |
T29 |
1997-2010 |
Sentence |
denotes |
G GM Mn Total |
T30 |
2011-2066 |
Sentence |
denotes |
Age (years) No. of patients % (No) % (No) % (No) % (No) |
T31 |
2067-2110 |
Sentence |
denotes |
20–49 25 24 (6) 0.00 (0) 4.00 (1) 24.00 (6) |
T32 |
2111-2158 |
Sentence |
denotes |
50–64 57 12.28 (7) 8.77 (5) 1.75 (1) 21.05 (12) |
T33 |
2159-2205 |
Sentence |
denotes |
≥65 99 19.19 (19) 9.09 (9) 1.01 (1) 24.24 (24) |